Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
1189 | 2698 | 40.2 | 78% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
1423 | 7465 | BISPHOSPHONATES//ZOLEDRONIC ACID//BISPHOSPHONATE |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | ZOLEDRONIC ACID | Author keyword | 302 | 49% | 17% | 448 |
2 | SKELETAL RELATED EVENTS | Author keyword | 181 | 80% | 4% | 111 |
3 | BONE METASTASES | Author keyword | 156 | 30% | 16% | 433 |
4 | SKELETAL RELATED EVENT | Author keyword | 89 | 92% | 1% | 35 |
5 | BISPHOSPHONATES | Author keyword | 85 | 17% | 18% | 474 |
6 | BONE METASTASIS | Author keyword | 56 | 20% | 10% | 258 |
7 | BISPHOSPHONATE | Author keyword | 39 | 15% | 9% | 244 |
8 | METASTATIC BONE DISEASE | Author keyword | 37 | 56% | 2% | 44 |
9 | PAMIDRONATE | Author keyword | 36 | 25% | 5% | 123 |
10 | UNIT CLIN ONCOL | Address | 34 | 35% | 3% | 78 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | ZOLEDRONIC ACID | 302 | 49% | 17% | 448 | Search ZOLEDRONIC+ACID | Search ZOLEDRONIC+ACID |
2 | SKELETAL RELATED EVENTS | 181 | 80% | 4% | 111 | Search SKELETAL+RELATED+EVENTS | Search SKELETAL+RELATED+EVENTS |
3 | BONE METASTASES | 156 | 30% | 16% | 433 | Search BONE+METASTASES | Search BONE+METASTASES |
4 | SKELETAL RELATED EVENT | 89 | 92% | 1% | 35 | Search SKELETAL+RELATED+EVENT | Search SKELETAL+RELATED+EVENT |
5 | BISPHOSPHONATES | 85 | 17% | 18% | 474 | Search BISPHOSPHONATES | Search BISPHOSPHONATES |
6 | BONE METASTASIS | 56 | 20% | 10% | 258 | Search BONE+METASTASIS | Search BONE+METASTASIS |
7 | BISPHOSPHONATE | 39 | 15% | 9% | 244 | Search BISPHOSPHONATE | Search BISPHOSPHONATE |
8 | METASTATIC BONE DISEASE | 37 | 56% | 2% | 44 | Search METASTATIC+BONE+DISEASE | Search METASTATIC+BONE+DISEASE |
9 | PAMIDRONATE | 36 | 25% | 5% | 123 | Search PAMIDRONATE | Search PAMIDRONATE |
10 | DENOSUMAB | 31 | 25% | 4% | 106 | Search DENOSUMAB | Search DENOSUMAB |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | SKELETAL COMPLICATIONS | 399 | 64% | 14% | 391 |
2 | ORAL CLODRONATE | 234 | 85% | 5% | 122 |
3 | ZOLEDRONIC ACID | 200 | 26% | 24% | 653 |
4 | ADJUVANT CLODRONATE TREATMENT | 156 | 78% | 4% | 103 |
5 | SKELETAL RELATED EVENTS | 135 | 65% | 5% | 129 |
6 | ADVANCED MULTIPLE MYELOMA | 116 | 64% | 4% | 115 |
7 | PAMIDRONATE | 80 | 24% | 11% | 292 |
8 | METASTATIC BONE DISEASE | 64 | 52% | 3% | 87 |
9 | BISPHOSPHONATES | 63 | 16% | 14% | 369 |
10 | CLODRONATE | 59 | 36% | 5% | 133 |
Journals |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | JOURNAL OF BONE ONCOLOGY | 13 | 43% | 1% | 23 |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Guidance on the use of bisphosphonates in solid tumours: recommendations of an international expert panel | 2008 | 231 | 113 | 72% |
Effects of Bone-Targeted Agents on Cancer Progression and Mortality | 2012 | 48 | 69 | 72% |
Bisphosphonates in breast cancer | 2015 | 3 | 48 | 69% |
Denosumab in patients with cancer and skeletal metastases: A systematic review and meta-analysis | 2013 | 24 | 49 | 61% |
The Key Role of Bisphosphonates in the Supportive Care of Cancer Patients | 2014 | 8 | 153 | 78% |
Adjuvant Therapy With Zoledronic Acid in Patients With Breast Cancer: A Systematic Review and Meta-Analysis | 2013 | 26 | 38 | 50% |
Metastasis to bone: Causes, consequences and therapeutic opportunities | 2002 | 1098 | 59 | 29% |
Direct and indirect anticancer activity of bisphosphonates: A brief review of published literature | 2012 | 32 | 87 | 72% |
Mechanisms of disease: Mechanisms of bone metastasis | 2004 | 802 | 78 | 24% |
Bisphosphonates and cancer-induced bone disease: Beyond their antiresorptive activity | 2005 | 132 | 19 | 89% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | UNIT CLIN ONCOL | 34 | 35% | 2.9% | 78 |
2 | WESTON PK HOSP | 17 | 39% | 1.3% | 34 |
3 | CLIN ENDOCRINOL BONE DIS | 6 | 71% | 0.2% | 5 |
4 | SUPPORT CARE CLIN | 4 | 47% | 0.3% | 7 |
5 | CR UK YCR SHEFFIELD CANC | 3 | 35% | 0.3% | 8 |
6 | MULTIPLE MYELOMA BONE METASTASIS PROGRAM | 3 | 100% | 0.1% | 3 |
7 | YORKSHIRE CANC CLIN ONCOL | 3 | 45% | 0.2% | 5 |
8 | OSTEONCOL RARE TUMORS | 3 | 38% | 0.2% | 6 |
9 | ENDOCRINOL BREAST CANC | 3 | 60% | 0.1% | 3 |
10 | OSTEOONCOL | 3 | 60% | 0.1% | 3 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000216332 | OSTEOBLASTIC METASTASIS//3 D COLLAGEN//AHTO 7 |
2 | 0.0000210830 | BRONJ//OSTEONECROSIS OF THE JAW//ONJ |
3 | 0.0000105013 | BONE TARGETING//OSTEOTROPIC DRUG DELIVERY SYSTEM//FARNESYL PYROPHOSPHATE SYNTHASE |
4 | 0.0000094482 | UNIT MUSCULOSKELETAL SURG//IMPENDING FRACTURE//PATHOLOGIC FRACTURE |
5 | 0.0000089303 | NEUROSYST//MOL NEUROBIOL PAIN//BMS182874 5 DIMETHYLAMINO N 3 4 DIMETHYL 5 ISOXAZOLYD 1 NAPHTHALENESULFONAMIDE |
6 | 0.0000088802 | MYELOMA BONE DISEASE//CAM DR//HEIM |
7 | 0.0000081656 | ALENDRONATE//RISEDRONATE//BISPHOSPHONATES |
8 | 0.0000080110 | RHENIUM 186 HEDP//BONE PAIN PALLIATION//STRONTIUM 89 |
9 | 0.0000072674 | PARATHYROID HORMONE RELATED PROTEIN//PTHRP//PARATHYROID HORMONE RELATED PEPTIDE |
10 | 0.0000064564 | PALLIATIVE RADIOTHERAPY//FACILITY SURVEY//PAIN FLARE |